Browsing by Subject "Response rate"

Now showing items 1-3 of 3

    • Article  

      Chemotherapy in clear cell sarcoma 

      Jones, Robin Lewis; Constantinidou, Anastasia; Thway, K.; Ashley, Sue; Scurr, Michelle R.; Al-Muderis, Omar; Fisher, Cyril; Antonescu, Cristina R.; D'Adamo, David R.; Keohan, Mary Louise; Maki, Robert G.; Judson, Ian Robert (2011)
      Clear cell sarcoma is a rare translocation-related sarcoma. There have been few studies documenting the response rate and progression-free survival in clear cell sarcoma patients treated with palliative chemotherapy. The ...
    • Article  

      Role of palliative chemotherapy in advanced epithelioid sarcoma 

      Jones, Robin Lewis; Constantinidou, Anastasia; Olmos, David; Thway, K.; Fisher, Cyril; Al-Muderis, Omar; Scurr, Michelle R.; Judson, Ian Robert (2012)
      Background: Epithelioid sarcoma is a rare soft tissue sarcoma subtype. The response of this disease to chemotherapy is not well described. The aim of this study was to investigate the response rate and progression-free ...
    • Article  

      A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: A translational research study of the Hellenic Cooperative Oncology Group (HeCOG) 

      Pentheroudakis, George; Kotoula, V.; Fountzilas, E.; Kouvatseas, G.; Basdanis, G.; Xanthakis, I.; Makatsoris, T.; Charalambous, E.; Papamichael, D.; Samantas, E.; Papakostas, P.; Bafaloukos, Dimitrios; Razi, E. D.; Christodoulou, C.; Varthalitis, I.; Pavlidis, Nicholas; Fountzilas, George (2014)
      Background: Bevacizumab, an antibody neutralizing Vascular Endothelial Growth Factor (VEGF), is licensed for the management of patients with advanced colon cancer. However, tumor biomarkers identifying the molecular tumor ...